Tag Archives: Sony
Fantastic Five Consumer Goods Stocks: Sony, LeapFrog Enterprises, Under Armour, Deckers Outdoor, Boulder Brands
Sony Corporation (ADR) (NYSE:SNE) lower its sales targets for digital cameras, smart phones and tablets by 13-17% for the year to finish-March 2015, however reported there were “encouraging” indications of a revival in its electronics business.
Sony Corporation (ADR) (NYSE:SNE) …
Sprint Nextel (NYSE:S) Gets Support from ISS, Sony (NYSE:SNE) Denies Criticism about Entertainment Sale
The third biggest wireless carrier in the US, Sprint Nextel Corp. (NYSE:S) gets Institutional Shareholder Services’ (ISS) support for its plan to finally purchase its subsidiary, Clearwire Corporation (CLWR).
ISS offers valuable investment decisions and corporate governance solutions to the …
Consumer Goods Sector Roundup: Post Holdings (NYSE:POST), General Motors (NYSE:GM) – POST, GM, TSLA, SNE, ACCO
Consumer goods sector finished higher on Monday’s trading session end. If we consider key movers of this sector so Tesla Motors Inc (NASDAQ:TSLA) and Sony Corporation (ADR) (NYSE:SNE) were major percentage gainers while key percentage decliner was ACCO Brands Corporation …
Consumer cyclical Sector Roundup: General Motors (NYSE:GM), Ford Motor (NYSE:F) – GM, F, HMC, ACW, SNE, PRKR
Consumer cyclical sector was major percentage decliner sector and marked a drop of -1.55% at the end of Monday trading session. If we look at the key movers of this sector so Accuride Corporation (NYSE:ACW) and Sony Corporation (ADR) (NYSE:SNE) …
Panasonic (NYSE:PC) Solar Panel Unit to Report Profit
The Osaka-based Panasonic Corporation (ADR) (NYSE:PC) reported on Monday that solar panel operation of the Japanese electronics maker will probably remain profitable amid growing demand from Japanese homeowners.
Solar panel unit head Kazuhiro Yoshida said in an interview in Tokyo …
United Therapeutics Corp. (NASDAQ:UTHR) Slapped by FDA, Sony’s (NYSE:SNE) Hitting US Unlocked
United Therapeutics Corp. (NASDAQ:UTHR) reported on Monday that the US Food and Drug Administration refused to accept the biotech company’s latest drug application for treprostinil diolamine tablets for the cure of pulmonary arterial hypertension (PAH).
United Therapeutics (UTHR) reported in …















